FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

20594211000001106: Co-beneldopa 12.5mg/50mg/5ml oral suspension (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Jun 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
69271401000001119 Co-beneldopa 12.5mg/50mg/5ml oral suspension (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
69271501000001115 Co-beneldopa 12.5mg/50mg/5ml oral suspension en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-beneldopa 12.5mg/50mg/5ml oral suspension Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route suspension.oral ontology form and route true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg/5ml oral suspension Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg/5ml oral suspension Has NHS dm+d (dictionary of medicines and devices) dose form indicator Continuous dose form indicator true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg/5ml oral suspension Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg/5ml oral suspension Is a Co-beneldopa true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg/5ml oral suspension Has active ingredient Levodopa true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg/5ml oral suspension Has active ingredient Benserazide true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg/5ml oral suspension Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg/5ml oral suspension Has specific active ingredient Benserazide hydrochloride true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg/5ml oral suspension Has specific active ingredient Levodopa true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg/5ml oral suspension VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg/5ml oral suspension VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg/5ml oral suspension Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Benserazide true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg/5ml oral suspension Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg/5ml oral suspension Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg/5ml oral suspension Has basis of strength substance Benserazide false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Co-beneldopa 12.5mg/50mg/5ml oral suspension (Special Order) Is a True Co-beneldopa 12.5mg/50mg/5ml oral suspension Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg/5ml oral suspension 1 ml Has VMP True Co-beneldopa 12.5mg/50mg/5ml oral suspension Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start